India to Peru: Erlotinib Export Trade Route

The India to Peru Erlotinib corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $152.0K USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's erlotinib manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $12.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 31.1%, placing it at rank #4 among India's top erlotinib export destinations globally.

On the import side, key buyers of Indian erlotinib in Peru include MSN LABS PERU SAC CAL., MSN LABS PERU SAC, TO THE ORDER MSN LABS PERU SAC CAL and 5 others. MSN LABS PERU SAC CAL. is the single largest importer with 3 shipments valued at $53.3K USD.

India's erlotinib exports to Peru are driven primarily by a handful of large-scale manufacturers. MSN LABORATORIES PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $12.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as lotyro 150mg 3x10's-erlotinib 150mg msn-pe and lotyro 150mg (3x10s)-erlotinib 150 mg msn-penos, suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MSN LABS PERU SAC CAL. is the largest importer with 3 shipments worth $53.3K USD — representing 35% of all erlotinib imports from India on this route. A total of 8 buyers are active on this corridor.